Skip to content

Clinical Evaluation of Two Daily Disposable Contact Lenses

Clinical Evaluation of Two Daily Disposable Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01875471
Enrollment
279
Registered
2013-06-11
Start date
2013-06-30
Completion date
2013-08-31
Last updated
2018-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error

Brief summary

The objective of this study is to compare the ease of removing two daily disposable soft contact lenses off the eye.

Interventions

Daily disposable soft contact lens to be worn at least 8 hours daily

Daily disposable contact lens to be worn at least 8 hours daily

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. The subject must be between 18 and 45 years of age (inclusive)with no presbyopic add. 2. The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form. This should be recorded on the Case Report Form (CRF). 3. The subject must be willing to wear the study lenses for at least 8 hours per day, at least 6 days between visits. 4. The subject must be a current successful spherical soft contact lens wearer in both eyes. 5. The subject must appear willing and able to adhere to the instructions set forth in this clinical protocol. 6. The subject's subjective refraction must result in a vertex corrected spherical contact lens prescription in the range of -1.00D to -6.00D (inclusive) in each eye. 7. The subject's refractive astigmatism must be less than or equal to -0.75D in both eyes. 8. The subject must have corrective visual acuity of 6/9 (20/30) or better in each eye. 9. The subject must require a visual correction in both eyes (no monofit or monovision allowed).

Exclusion criteria

1. Any ocular or systemic allergies or diseases that may interfere with contact lens wear. 2. Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. 3. Clinically significant (Grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or infiltrates or any other abnormalities of the cornea which would contraindicate contact lens wear. 4. Clinically significant (Grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear. 5. Any ocular infection. 6. Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear. 7. Currently pregnant or lactating (subject who become pregnant during the study will be discontinued). 8. Diabetes. 9. Infectious diseases (e.g. hepatitis, tuberculosis) or an immunosuppressive disease (e.g. HIV). 10. Amblyopia 11. Evidence of lid abnormality or infection (including blepharitis/meibomitis) 12. Conjunctival abnormality or infection. 13. Any active ocular disease. 14. Employee or family member of the staff of the investigational site.

Design outcomes

Primary

MeasureTime frameDescription
Subjective Ease of Lens RemovalDay 7After 1-week of lens wear, each subject was asked to rate a question, 'Ease of taking the lenses off of your eyes', using 5-point scale (1=Excellent, 2=Very Good, 3=Good, 4=Fair, 5=Poor).

Countries

United Kingdom

Participant flow

Pre-assignment details

A total of 279 subjects were enrolled in the study; 4 did not meet the eligibility criteria, 2 prematurely discontinued and 273 completed the study. Of those 273 completers, 23 were excluded from the primary analysis due to major protocol deviations; hence, 250 completed the study per protocol and were included in the analysis.

Participants by arm

ArmCount
Delefilcon A
Spherical daily disposable soft contact lens delefilcon A: Daily disposable soft contact lens to be worn at least 8 hours daily
137
Narafilcon A
Spherical daily disposable soft contact lens Class 1 UV blocking narafilcon A: Daily disposable contact lens to be worn at least 8 hours daily
138
Total275

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event01
Overall StudyUnsatisfactory Lens Fitting10

Baseline characteristics

CharacteristicDelefilcon ANarafilcon ATotal
Age, Categorical
<=18 years
11 Participants9 Participants20 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
126 Participants129 Participants255 Participants
Age, Continuous30.0 years
STANDARD_DEVIATION 8.17
29.0 years
STANDARD_DEVIATION 7.69
29.5 years
STANDARD_DEVIATION 7.93
Region of Enrollment
United Kingdom
88 participants87 participants175 participants
Region of Enrollment
United States
49 participants51 participants100 participants
Sex: Female, Male
Female
99 Participants76 Participants175 Participants
Sex: Female, Male
Male
38 Participants62 Participants100 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1370 / 138
serious
Total, serious adverse events
0 / 1370 / 138

Outcome results

Primary

Subjective Ease of Lens Removal

After 1-week of lens wear, each subject was asked to rate a question, 'Ease of taking the lenses off of your eyes', using 5-point scale (1=Excellent, 2=Very Good, 3=Good, 4=Fair, 5=Poor).

Time frame: Day 7

ArmMeasureGroupValue (NUMBER)
Delefilcon ASubjective Ease of Lens RemovalVery Good23 participants
Delefilcon ASubjective Ease of Lens RemovalFair23 participants
Delefilcon ASubjective Ease of Lens RemovalGood24 participants
Delefilcon ASubjective Ease of Lens RemovalPoor12 participants
Delefilcon ASubjective Ease of Lens RemovalExcellent45 participants
Narafilcon ASubjective Ease of Lens RemovalPoor0 participants
Narafilcon ASubjective Ease of Lens RemovalExcellent76 participants
Narafilcon ASubjective Ease of Lens RemovalVery Good34 participants
Narafilcon ASubjective Ease of Lens RemovalGood10 participants
Narafilcon ASubjective Ease of Lens RemovalFair3 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026